Transmission-blocking vaccine of vivax malaria (Q35051320)

6 August 2017

1 reference

title

Transmission-blocking vaccine of vivax malaria (English)

1 reference

6 August 2017

0 references

0 references

1 reference

Takafumi Tsuboi

1

0 references

author name string

Mayumi Tachibana

series ordinal

2

1 reference

PubMed ID

12543142

6 August 2017

Osamu Kaneko

series ordinal

3

1 reference

PubMed ID

12543142

6 August 2017

Motomi Torii

series ordinal

4

1 reference

6 August 2017

1 March 2003

1 reference

Parasitology International

6 August 2017

1 reference

6 August 2017

52

1 reference

6 August 2017

1

1 reference

6 August 2017

1-11

1 reference

The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

The neglected burden of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Transmission-blocking vaccines: uses and current status of development

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Transmission blocking malaria vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Malaria eradication on islands

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Child mortality and malaria transmission intensity in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Minimal efficacy requirements for malarial vaccines to significantly lower transmission in epidemic or seasonal malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Successful immunization against the sexual stages of Plasmodium gallinaceum

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Malaria transmission blocked by immunisation with gametes of the malaria parasite

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Malaria immunization in Rhesus monkeys. A vaccine effective against both the sexual and asexual stages of Plasmodium knowlesi

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Immunisation against gametes and asexual erythrocytic stages of a rodent malaria parasite

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Identification of additional members define a Plasmodium falciparum gene superfamily which includes Pfs48/45 and Pfs230.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

A central role for P48/45 in malaria parasite male gamete fertility

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Cloning and expression of the gene for Plasmodium falciparum transmission-blocking target antigen, Pfs230

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Properties of epitopes of pfs 48/45, a target of transmission blocking monoclonal antibodies, on gametes of different isolates of plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface antigen Pfs230 are all complement-fixing

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Target antigens of transmission-blocking immunity on gametes of plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Recombinant Pfs230, a Plasmodium falciparum gametocyte protein, induces antisera that reduce the infectivity of Plasmodium falciparum to mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Comparison of the primary structure of the 25 kDa ookinete surface antigens of Plasmodium falciparum and Plasmodium gallinaceum reveal six conserved regions

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Structure and expression of a post-transcriptionally regulated malaria gene encoding a surface protein from the sexual stages of Plasmodium berghei

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Primary structure of a novel ookinete surface protein from Plasmodium berghei.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Comparison of Plasmodium yoelii ookinete surface antigens with human and avian malaria parasite homologues reveals two highly conserved regions.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Presence of three distinct ookinete surface protein genes, Pos25, Pos28-1, and Pos28-2, in Plasmodium ovale.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Biosynthesis of two stage-specific membrane proteins during transformation of Plasmodium gallinaceum zygotes into ookinetes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Minimal variation in a vaccine candidate from the sexual stage of plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Single amino acid variation in the ookinete vaccine antigen from field isolates of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Minimal variation in the Pfs28 ookinete antigen from Philippine field isolates of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Restricted or absent immune responses in human populations to plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Production, purification and immunogenicity of a malaria transmission-blocking vaccine candidate: TBV25H expressed in yeast and purified using nickel-NTA agarose.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

The chitinase PfCHT1 from the human malaria parasite Plasmodium falciparum lacks proenzyme and chitin-binding domains and displays unique substrate preferences

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Chitinases of the avian malaria parasite Plasmodium gallinaceum, a class of enzymes necessary for parasite invasion of the mosquito midgut.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Disruption of Plasmodium falciparum chitinase markedly impairs parasite invasion of mosquito midgut

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Micronemal transport of Plasmodium ookinete chitinases to the electron-dense area of the apical complex for extracellular secretion

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

CTRP is essential for mosquito infection by malaria ookinetes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Targeted disruption of the plasmodium berghei CTRP gene reveals its essential role in malaria infection of the vector mosquito

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Developmental arrest of the human malaria parasite Plasmodium falciparum within the mosquito midgut via CTRP gene disruption

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Anti-mosquito midgut antibodies block development of Plasmodium falciparum and Plasmodium vivax in multiple species of Anopheles mosquitoes and reduce vector fecundity and survivorship

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Continuous in vitro propagation of the malaria parasite Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Transmission blocking immunity in Plasmodium vivax malaria: antibodies raised against a peptide block parasite development in the mosquito vector

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Transmission blocking immunity to human Plasmodium vivax malaria in an endemic population in Kataragama, Sri Lanka

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

Sequence diversity in rodent malaria of the Pfs28 ookinete surface antigen homologs.

1 reference

https://api.crossref.org/works/10.1016%2FS1383-5769%2802%2900037-5

7 January 2021

10.1016/S1383-5769(02)00037-5

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12543142